Follow The Filings

MLAB Mesa Laboratories

Mesa Laboratories earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by MLAB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MLAB insider trades
  • $1.4M bought by 4 insiders
  • $1M sold by 2 insiders outside a trading plan
  • $117K sold by 1 insider under 10b5-1 plans
  1. John James Sullivan Director
    Sale
    $800K 7,093 shares at $112.80 29% of stake
    Traded Aug 13 Filed Aug 17
  2. Siddhartha Kadia CEO
    Buy
    $800K 7,093 shares at $112.80 New stake
    Traded Aug 13 Filed Aug 17
  3. R Tony Tripeny Director
    Buy
    $102K 900 shares at $113.69 +17% to stake
    Traded Aug 13 Filed Aug 17
  4. Brian David Archbold SVP Operations
    Sale
    $225K 2,516 shares at $89.50 28% of stake
    Traded Jun 22 Filed Jun 23
  5. Brian David Archbold SVP Operations
    Planned sale
    $117K 1,151 shares at $101.27 24% of stake
    Traded Jun 16 Filed Jun 17
  6. Shiraz Shabanali Ladiwala Director
    Buy
    $253K 3,500 shares at $72.23 +70% to stake
    Traded Mar 10 Filed Mar 10
  7. Mark Christopher Capone Director
    Buy
    $99K 1,301 shares at $76.35 +61% to stake
    Traded Mar 10 Filed Mar 10
  8. R Tony Tripeny Director
    Buy
    $100K 1,315 shares at $76.00 +32% to stake
    Traded Mar 10 Filed Mar 10

Also filed in the last 12 months, not counted as buying or selling: 16 option exercises, 4 sales to cover taxes, 3 stock grants, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 2.05,7.01,9.01
SCHEDULE 13G —
8-K 5.07
8-K 2.02,9.01
10-Q FORM 10-Q
8-K 5.05,9.01
DEF 14A FORM DEF 14A
SCHEDULE 13G/A —
8-K 5.02,9.01
10-K FORM 10-K
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.